EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Jan 14, 2021
Document Date
Dec 31, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
OCUMENSION THERAPEUTICS
EyePoint Pharmaceuticals